1.
36-Month Multi-Centre Outcomes of Combined Phacoemulsification and Hydrus Microstent Implantation in Eyes with Normal Tension Glaucoma.
Ang Bryan Chin Hou, Betzler Bjorn Kaijun, Sim Jackie Jia Lin, Ramanathan Rajesh, Hong Ashley Shuen Ying, Chua Chun Hau et al.
J GlaucomaMar 20260 citationsCohort Study
Phaco-Hydrus in NTG eyes sustainedly reduced glaucoma medication burden over 36 months, without significant IOP reduction. This suggests its role is primarily medication reduction, not IOP lowering.